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Each month, Chemistry & Biology Select highlights a selection of research reports from the recent
literature. These highlights are a snapshot of interesting research done across the field of chemical
biology. This month’s Select highlights reports on the new antibiotic teixobactin, the role of an
inositol pyrophosphate IP7 in tumor growth and metastasis, a method to improve performance
of dyes used in imaging, and themechanismof antiviral action for the antifungal agent, itraconazole.The image shows a multichannel device, iChip,
which was used to simultaneously isolate and
grow uncultured bacteria. In the experimental
set up employed by authors, the iChip was
loaded with a diluted soil sample and contained
approximately one bacterial cell per channel.
iChip was covered with two semipermeable
membranes and placed back in the soil,Resistance Is Futile If You Are Armed with
Teixobactin
Discovery of an antibiotic that does not lead to development of resistance is an
achievement likely to be considered ‘‘the Holy Grail’’ of antibiotic development.
This is because we are in big trouble as bacteria develop drug resistance and
some even become invincible superbugs. One of the most successful classes
of antibiotics is natural products (NP), small molecules produced by a range
of organisms, including bacteria. The range of bacterial NP producers that
have been extensively studied is limited, however, given that themajority of bac-
terial species do not grow under laboratory conditions. In practical terms, this
means that we can currently access only a tiny fraction of NP chemical space
and that diving into the world of uncultured bacteria is likely to yield surprises.
One of the first of these surprises is teixobactin, a new antibiotic that Ling et al.
identified from uncultured bacteria. Teixobactin is an 11 residue macrocyclic
depsipeptide and a foundingmember of a new class of lipid II binding antibiotics.
Teixobactin has an exceptional activity profile against Gram-positive pathogens,
has no toxicity against mammalian cells, does not lead to emergence of resis-
tance inMycobacterium tuberculosis and Staphylococcus aureus, and is effica-
cious inseveralmousemodelsof infection.Mechanismofactionstudiesestablish
that teixobactin interacts with precursors of peptidoglycan and wall teichoic acidallowing uncultured bacteria to grow in their
natural environment supplemented with
nutrients and growth factors. This resulted in
about 50% growth recovery, thus significantly
outperforming conventional methods. Photo
courtesy of Slava Epstein.
ITZ has antifungal, antitumoral, and antiviral
effects. The antifungal activity of ITZ is exerted
by inhibition of the fungal enzyme CYP51,
an enzyme involved in ergosterol biosynthesis.
The antiviral activity of ITZ is mediated through
inhibition of the cholesterol- and PI4P-shuttling
activities of OSBP. ITZ inhibits tumor formation
through at least three different pathways
(vascular endothelial growth factor receptor 2
[VEGFR2] functioning, mTOR signaling, and
Hedgehog [Hh] signaling), but the underlying
mechanisms are unknown. Whether the
antitumoral activity of ITZ is linked to its effect
on OSBP remains to be determined. Image
courtesy of J. Strating.by binding the pyrophosphate-
sugar moiety of these molecules.
The fact that teixobactin targets
are not proteins and that the teixo-
bactin producer is protected from
teixobactin not via an alternative
pathway for cell wall synthesis but by transporting teixobactin across the outer
membrane suggest that any emergence of resistance to teixobactin will be very
slow. Hopefully, by then, wewill see the discovery of many other powerful antibi-
otics from uncultured bacteria, andwewill better understand how to prevent and
control bacterial drug resistance.
Ling et al. (2015). Nature 517, 455-459. http://dx.doi.org/10.1038/nature14098
From an Antifungal to an Antiviral
If you have ever had a fungal infection of finger nails or toe nails, chances are that
youmight have beenprescribed itraconazole (ITZ). ITZ has been in use as an anti-
fungal agent for decades, and it is used to treat a broad range of fungal infections,
including life-threatening invasivemycoses. The antifungal activity of ITZ is due to
its ability to inhibit synthesis of ergosterol, the essential fungal sterol, by inhibiting
a cytochrome P450 essential for this process. Recently, ITZ was found to also
possess antitumoral activity, for which it currently is in clinical trials. The antitu-
moral activity is exerted by inhibition of angiogenesis and theHedgehog signaling
pathway through P450-independent mechanisms, but the molecular targets and
mechanism are poorly understood.
Drug repurposing is a hotly pursued strategyof finding additional uses for drugs
that have been in long-term use and are known to be well-tolerated and safe.Chemistry & Biology 22, February 19, 2015 ª2015 Elsevier Ltd All rights reserved 159
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SelectStrating et al. show that ITZ has an additional, broad-range antiviral activity against enteroviruses and cardioviruses. ITZ was
found to affect RNA replication. The authors rule out that this effect was due to ITZ-mediated inhibition of its known targets.
Instead, Strating et al. show that ITZ targets oxysterol-binding protein (OSBP) and OSBP-related protein 4 (ORP4) and affects
different viruses that depend on OSBP function, including hepatitis C virus (HCV). ITZ inhibits OSBP-mediated transport of
cholesterol fromER toGolgi, andphosphatidylinositol 4-phosphate (PI4P) fromGolgi toER, inboth infectedanduninfectedcells.
More generally, Strating et al. suggest that OSBP and ORP4 are involved in enterovirus replication, although a detailed mecha-
nism and the potential roles of other ORPs in this process are yet to be established. From the drug repurposing perspective, the
authors present a strongcase that ITZ andother compounds that bindOSBPandORP4might have antiviral activity.Whether the
anticancer activity reported for ITZmight to someextent bedue to itsOSBP targeting is unknown and remains to bedetermined.
Strating et al. (2015) Cell Reports 10, 600-615. http://dx.doi.org/10.1016/j.celrep.2014.12.054
IP7 and Cancer
Inositol pyrophosphates are a class of highly energetic inositol polyphosphate molecules involved in numerous physiological
processes. A representative member of the family is diphosphoinositol pentakisphosphate (IP7), and one of the enzymes
involved in its production is inositol hexakisphosphate (IP6) kinase 2 (IP6K2). Although known to control a range of diverse
cellular functions, a link between inositol pyrophosphates and cancer has not been established.
Rao et al. now report that IP7producedby IP6K2 leads to nuclear sequestration of liver kinaseB1 (LKB1), which in turn results
in tumor growth and metastasis. The initial observation that motivated further inquiry was that cell lines with IP6K2 deletion
spread more slowly than wild-type and displayed a decrease of cell-matrix adhesion. The authors show that IP6K2 promotes
cell-matrix interactions and suppresses cell-cell adhesion, both in cell-based assays and in animalmodels. Using a catalytically
deadmutant to examine whether IP6K2 activity is important for observed effects, Rao et al. document that production of IP7 is
necessary for upregulation of focal adhesion anddownregulation of cell-cell adhesion and for effects in live animals.Mechanis-
tically, the authors present evidence that IP6K2 engages LKB1 directly and that locally produced IP7 inhibits LKB1 phosphor-
ylation, thus resulting in LKB1 nuclear sequestration. The authors suggest that IP7 might exert its effect by either inhibiting a
cellular factor that holds LKB1 in the cytosol or by interfering with an upstream kinase that phosphorylates LKB1, which results
in transport of LKB1 into the nucleus. Although finermechanistic details remain to be established, Rao et al. show that IP6K2 is
important for cancer cell aggressiveness and that this kinase might represent a potential anticancer drug target.
Rao et al. (2015). Proc. Nat. Acad. Sci. USA. Published online January 23, 2015. http://dx.doi.org/10.1073/pnas.1424642112The image shows a live U2OS cell nucleus. The
magenta is a super-resolution dSTORM image
ofHaloTag-histone 2B labeledwith Janelia Fluor
646. The green is a diffusion-coefficient map of
SnapTag-TetR labeled with Janelia Fluor 549.
Partial structures of the JF646 and JF549 dyes
are shown with magenta and green outer glow,
respectively. Image courtesy of L. Lavis.A Way to Better, Brighter Dyes
The use of fluorescent proteins (FPs), themost famous of which is GFP, has revo-
lutionized biology and our ability to visualize cellular processes. FPs are not
without shortcomings, however, and research into developing and employing
small molecule fluorophores to be used in the same context as FPs has been
booming. Rhodamine dyes are a large family of fluorophores widely used for
biochemical and biological applications including live-cell imaging. However,
only a subset of rhodamines has good cell permeability, mostly based on classic,
unoptimized structures. Developing chemical strategies that improve brightness
and stability in the intracellular milieu while retaining cell permability could enable
new and improved cellular imaging experiments.
Grimm et al. develop a strategy for redesigning fluorophores to improve their
brightness. They use rhodamines as their proof-of-concept example and initially
focus on dissecting the molecular basis for observed optical properties. Many
fluorophores, such as tetramethylrhodamine (TMR), contain a N,N-dimethyla-
mino group that can promote a twisted internal charge transfer (TICT) state,
thereby decreasing the fluorescence lifetime, quantum efficiency, and photo-
stability. Inspired by molecular modeling, they prepared a derivative of TMR
that would disfavor TICT, where a four-membered azetidine ring replaces the
N,N-dimethylamino group. This compound has excellent optical properties,
cell membrane permeability, stability, and brightness. Grimm et al. name it
JF549 (Janelia Fluor 549), where549 nm is the lmax, anddemonstrate that it yields
significantly improved single-molecule tracking and super-resolution imaging inside cellswhen compared to TMR. The authors
go on to show that substituting N,N-dimethylamino groups with azetidines yields increased quantum yields in number
of different dyes, including carbon- and silicon-containing rhodamine analogs as well as coumarin, naphthalimide, acridine,
rhodol, and oxazine fluorophores. Grimm et al. therefore highlight that the strategy they developed is a general approach for
improvingbrightness andphotostability of smallmolecule organic dyes that display TICT-state-dependent nonradiative decay.
Grimm et al. (2015) Nat. Methods. Published online January 19, 2015. http://dx.doi.org/10.1038/nmeth.3256
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